TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24702987

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 22143257

Group type: EXPERIMENTAL
Intervention: Daily educational text messages for 180 days
Number of subjects: 962
Study: 21695161

Group type: EXPERIMENTAL
Intervention: Praziquantel 40 mg/kg
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Praziquantel 60 mg/kg
Number of subjects: 856
Study: 19855259

Group type: EXPERIMENTAL
Intervention: High-resolution ultrasound (HRUS)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Multidetector computed tomography (CT)
Number of subjects: 144
Study: 16965492

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of 4 mg triamcinolone acetonide
Number of subjects: 17
Study: 14993078

Group type: EXPERIMENTAL
Intervention: Chizukit (herbal preparation containing 50 mg/mL of echinacea, 50 mg/mL of propolis, and 10 mg/mL of vitamin C)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo elixir
Number of subjects: 430
Study: 11469296

Group type: EXPERIMENTAL
Intervention: Automated instrumentation using KaVo‐Endo Flash device with K‐Flexofiles
Number of subjects: 120

Group type: COMPARATOR
Intervention: Manual instrumentation using K‐Flexofiles and Hedstrom files
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Automated instrumentation using ProFile system with rotary nickel‐titanium instruments
Number of subjects: 120
Study: 9088587

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg day‐1 for 14 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Desipramine (100 mg)
Number of subjects: 12
Study: 8259749

Group type: EXPERIMENTAL
Intervention: Early induction with oxytocin (6 hours after PROM)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Late induction with oxytocin (24 hours after PROM)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Both early and late induction groups
Number of subjects: 362
Study: 3883843

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 40
Study: 30234415

Group type: EXPERIMENTAL
Intervention: Clovinol (250 mg per day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27396951

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Bevacizumab (alone or in combination with CCNU)
Number of subjects: 473
Study: 25072529

Group type: EXPERIMENTAL
Intervention: Capacitive radio-frequency diathermy (CRFD) local application (30 min)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Capacitive radio-frequency diathermy (CRFD) local application followed by whole-segment application (20 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (CRFD treatment followed by supplementary application)
Number of subjects: 27
Study: 22772854

Group type: EXPERIMENTAL
Intervention: Borghi's approach (soft tissue depression)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chayen's approach (iliac crest)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Borghi's approach (soft tissue depression) in obese patients (BMI ≥30 kg/m(2))
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chayen's approach (iliac crest) in obese patients (BMI ≥30 kg/m(2))
Number of subjects: 54
Study: 20192552

Group type: EXPERIMENTAL
Intervention: Tone-Square Pairings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tone-Alone Presentations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expectancy of the Square
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RT Performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RT Perruchet Effect
Number of subjects: 0
Study: 18983246

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment during pregnancy
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo treatment during pregnancy
Number of subjects: 387
Study: 16028788

Group type: EXPERIMENTAL
Intervention: Training group (hearing aid fitting + home education program)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (hearing aid fitting)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study: 12492183

Group type: EXPERIMENTAL
Intervention: Test-and-treat intervention (TTI)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Usual care control (UCC)
Number of subjects: 93
Study: 10029033

Group type: EXPERIMENTAL
Intervention: Standardized protocol for ICP management
Number of subjects: 24
Study: 7496683

Group type: EXPERIMENTAL
Intervention: Expiration group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inspiration group
Number of subjects: 100
Study: 2036812

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 7144047

Group type: EXPERIMENTAL
Intervention: Active group (41 children) with frequent ambulatory checkups (22 times)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nonactive group (20 children) with infrequent ambulatory checkups (8 times)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups underwent treatment based on diet and increased physical exercise for two years
Number of subjects: 61
Study: 30690551

Group type: EXPERIMENTAL
Intervention: 4 hours of darkness (4D)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: 10 hours of darkness (10D)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Increasing darkness (1D, 4D, 7D, 10D)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Age and gender factors
Number of subjects: 4000
Study: 28074446

Group type: EXPERIMENTAL
Intervention: Ixekizumab (160 mg at Week 12, followed by Q4W for Weeks 16-60)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etanercept (50 mg twice weekly for the first 12 weeks, followed by placebo at Week 12)
Number of subjects: 0
Study: 26057484

Group type: EXPERIMENTAL
Intervention: Collagen/thrombin/autologous platelet haemostatic agent
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard haemostatic methods only (Control)
Number of subjects: 109
Study: 23592676

Group type: EXPERIMENTAL
Intervention: Higher protein diet (HP)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal protein diet (NP)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both diets (NP and HP)
Number of subjects: 43
Study: 21469388

Group type: EXPERIMENTAL
Intervention: gelatin sponge patch bonded repair group
Number of subjects: 112

Group type: COMPARATOR
Intervention: natural repair group
Number of subjects: 112
Study: 19460684

Group type: EXPERIMENTAL
Intervention: Inhaled dornase alfa administered 30 minutes before airway clearance therapy (ACT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled dornase alfa administered before bedtime or upon awakening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled dornase alfa
Number of subjects: 0
Study: 17011315

Group type: EXPERIMENTAL
Intervention: Baclofen (0.5 mg/kg)
Number of subjects: 30
Study: 15279069

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg, po)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CRH (1 microg/kg iv) given alone or after rosiglitazone
Number of subjects: 10
Study: 10682964

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1.0% twice daily
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1.0% three times daily
Number of subjects: 378

Group type: COMPARATOR
Intervention: Timolol 0.5% twice daily
Number of subjects: 378
Study: 9340014

Group type: EXPERIMENTAL
Intervention: lomeprol
Number of subjects: 1200

Group type: COMPARATOR
Intervention: iopromide
Number of subjects: 1200
Study: 8497972

Group type: EXPERIMENTAL
Intervention: Autologous drain-blood transfusion
Number of subjects: 56

Group type: COMPARATOR
Intervention: Homologous blood transfusion
Number of subjects: 56
Study: 3113975

Group type: EXPERIMENTAL
Intervention: Flunarizine (10 mg orally at bedtime)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flunarizine (10 mg at bedtime)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg) and gonadotropin releasing hormone (100 micrograms)
Number of subjects: 20
Study: 29273115

Group type: EXPERIMENTAL
Intervention: Bridges (1:1 match savings)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bridges PLUS (1:2 match savings)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care condition
Number of subjects: 48
Study: 27475887

Group type: EXPERIMENTAL
Intervention: Reduction in hazardous drinking
Number of subjects: 307

Group type: COMPARATOR
Intervention: Continued hazardous drinking
Number of subjects: 307

Group type: COMPARATOR
Intervention: Anxiety and depressive symptoms
Number of subjects: 307
Study: 25688038

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23015608

Group type: EXPERIMENTAL
Intervention: Universal alcohol screening and brief intervention (SBI) delivered by a practice nurse
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Universal alcohol screening and brief intervention (SBI) delivered by a doctor
Number of subjects: 1000000

Group type: COMPARATOR
Intervention: No programme
Number of subjects: 1000000
Study: 20875112

Group type: EXPERIMENTAL
Intervention: Child-centred diabetes information resources (diabetes diaries, carbohydrate recording sheets, information packs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Currently available standard practice
Number of subjects: 0
Study: 18231884

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sterile water injections
Number of subjects: 128
Study: 15193897

Group type: EXPERIMENTAL
Intervention: Healthy Directions‐Health Centers intervention
Number of subjects: 1088
Study: 11446242

Group type: EXPERIMENTAL
Intervention: Standard symptom checklist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified checklist with bogus items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both checklists
Number of subjects: 0
Study: 9609509

Group type: EXPERIMENTAL
Intervention: Peer counseling and leadership training program (8 weeks + 8 weeks reinforcement)
Number of subjects: 204
Study: 7509570

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (estradiol transdermal system [Estraderm TTS] plus chlormadinone)
Number of subjects: 499

Group type: COMPARATOR
Intervention: Symptomatic treatment (verapipride)
Number of subjects: 499
Study: 3281619

Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Captopril plus a diuretic
Number of subjects: 626

Group type: COMPARATOR
Intervention: Monotherapy (unspecified)
Number of subjects: 626
Study: 31627278

Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sedentary condition
Number of subjects: 68
Study: 28358253

Group type: EXPERIMENTAL
Intervention: 5.4 J/cm2 UV-A radiance (Group 1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 7.2 J/cm2 UV-A radiance (Group 2)
Number of subjects: 82
Study: 25463008

Group type: EXPERIMENTAL
Intervention: Medium fidelity simulation (3 sessions of 2 hours each)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Face-to-face lectures (3 lectures covering forensic science topics)
Number of subjects: 35
Study: 22986578

Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 2595

Group type: COMPARATOR
Intervention: Tamsulosin
Number of subjects: 2595

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2595
Study: 21598412

Group type: EXPERIMENTAL
Intervention: Auricular acupressure with Japanese Magnetic Pearl
Number of subjects: 55

Group type: COMPARATOR
Intervention: Auricular acupressure only (Control)
Number of subjects: 55
Study: 19910194

Group type: EXPERIMENTAL
Intervention: Breast conserving surgery plus radiotherapy (RT)
Number of subjects: 749

Group type: COMPARATOR
Intervention: Breast conserving surgery only
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Breast conserving surgery with or without RT
Number of subjects: 749
Study: 17130203

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12838696

Group type: EXPERIMENTAL
Intervention: Preserving external jugular vein and cervical plexus
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no preservation of external jugular vein and cervical plexus)
Number of subjects: 20
Study: 10674115

Group type: EXPERIMENTAL
Intervention: Inhalable heroin (combined with oral methadone), administered seven days per week, three times per day for a period of six to twelve months.
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Injectable heroin (combined with oral methadone), administered seven days per week, three times per day for a period of six to twelve months.
Number of subjects: 625
Study: 9341603

Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg/d
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Flutamide 500 mg/d
Number of subjects: 65
Study: 8408684

Group type: EXPERIMENTAL
Intervention: Condition One (happy events)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Condition Two (sad events)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Condition Three (control - geography article)
Number of subjects: 90
Study: 3317340

Group type: EXPERIMENTAL
Intervention: Captopril (50-100 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Verapamil (160-240 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril (50-100 mg/day) and Verapamil (160-240 mg/day)
Number of subjects: 8
Study: 30661686

Group type: EXPERIMENTAL
Intervention: FAVVA index
Number of subjects: 99
Study: 29906015

Group type: EXPERIMENTAL
Intervention: Mobile-teledermatology
Number of subjects: 0
Study: 26740194

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray 200 g plus nasal irrigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single nasal irrigation
Number of subjects: 0
Study: 24919388

Group type: EXPERIMENTAL
Intervention: Yawning in motion condition
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-yawning in motion condition
Number of subjects: 39
Study: 22592162

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (2 sessions per week for 4 weeks, each lasting 50 minutes)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 31
Study: 20443801

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants
Number of subjects: 11

Group type: COMPARATOR
Intervention: Early loaded implants
Number of subjects: 11
Study: 18777124

Group type: EXPERIMENTAL
Intervention: Home access to PA equipment
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Perceived satisfaction
Number of subjects: 205
Study: 16318157

Group type: EXPERIMENTAL
Intervention: Isolated electroacupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal electroacupuncture
Number of subjects: 100
Study: 12512664

Group type: EXPERIMENTAL
Intervention: Early treatment using air abrasion followed by placement of preventive resin restorations
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no early treatment)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Early treatment group
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 9809925

Group type: EXPERIMENTAL
Intervention: Carvedilol (2.5 mg once a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Metoprolol (30 mg once a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Doxazosin (0.5 mg once a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7806412

Group type: EXPERIMENTAL
Intervention: One-appointment root canal therapy using calcium hydroxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-appointment root canal therapy using calcium hydroxide
Number of subjects: 0
Study: 2528492

Group type: EXPERIMENTAL
Intervention: Human insulin infusion (0.7 mU kg‐1 min‐1 for 8 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: 0.15 mmol/l NaCl solution infusion over 8 hours (Control)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both interventions (Human insulin and NaCl)
Number of subjects: 7
Study: 4804455

Group type: EXPERIMENTAL
Intervention: Fenfluramine treatment without dietary restriction
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-calorie diet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low-calorie diet with fenfluramine
Number of subjects: 6
Study: 31724097

Group type: EXPERIMENTAL
Intervention: 5-0 Polypropylene (PP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-0 fast absorbing plain gut (FG)
Number of subjects: 0
Study: 31630445

Group type: EXPERIMENTAL
Intervention: Weekly adalimumab (ADAew)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study: 28807505

Group type: EXPERIMENTAL
Intervention: Self-reported delayed ejaculation (DE)
Number of subjects: 988

Group type: COMPARATOR
Intervention: No delayed ejaculation (no DE)
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Ejaculation time
Number of subjects: 988
Study: 26424327

Group type: EXPERIMENTAL
Intervention: self-management intervention
Number of subjects: 113

Group type: COMPARATOR
Intervention: education intervention
Number of subjects: 113
Study: 23750742

Group type: EXPERIMENTAL
Intervention: Oral naltrexone and brief behavioral counseling
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study: 21347224

Group type: EXPERIMENTAL
Intervention: pSG2.HBs vaccine followed by MVA.HBs vaccine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 3TC therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Prime-boost vaccine regimen (pSG2.HBs and MVA.HBs)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (Intramuscular rabies vaccine)
Number of subjects: 72
Study: 18645683

Group type: EXPERIMENTAL
Intervention: SK3530 (50, 100, or 150 mg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: SK3530
Number of subjects: 119
Study: 16446743

Group type: EXPERIMENTAL
Intervention: Individualised dietary and lifestyle counselling biannually
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1062
Study: 12750654

Group type: EXPERIMENTAL
Intervention: Low back pain >30 days at baseline
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Low back pain in year 0
Number of subjects: 2000
Study: 16497479

Group type: EXPERIMENTAL
Intervention: Gelclair (15 ml applied directly onto the wound 3 times per day, 1 hour before meals for 1 week)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ibuprofen (600 mg 3 times per day for 4 days)
Number of subjects: 60
Study: 10225169

Group type: EXPERIMENTAL
Intervention: Tramadol 3.0 mg kg‐1
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Pethidine 1.5 mg kg‐1
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.3 mg kg‐1
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (saline 0.02 ml kg‐1)
Number of subjects: 152
Study: 8934303

Group type: EXPERIMENTAL
Intervention: Codeine 25 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Codeine 50 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Codeine (both doses)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Morphine and Codeine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: C6G, Codeine, M3G
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: M3G
Number of subjects: 13
Study: 1882280

Group type: EXPERIMENTAL
Intervention: Group I: Methotrexate and fluorouracil once a week and cyclophosphamide every other day for 15 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Group II: All drugs given simultaneously once weekly for 15 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Group I vs Group II
Number of subjects: 66
Study: 6888268

Group type: EXPERIMENTAL
Intervention: Glucagon administration
Number of subjects: 28
Study: 31204837

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 47
Study: 28128967

Group type: EXPERIMENTAL
Intervention: Effective mandibular advancement device
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 150
Study: 27043756

Group type: EXPERIMENTAL
Intervention: Shape Program intervention (12-month digital health treatment)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 194
Study: 25253539

Group type: EXPERIMENTAL
Intervention: Web-based coaching program with telephone counseling
Number of subjects: 168

Group type: COMPARATOR
Intervention: Usual care without web-based coaching
Number of subjects: 168
Study: 23114016

Group type: EXPERIMENTAL
Intervention: Triple therapy plus probiotics (Probinul - Cadigroup)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Triple therapy alone
Number of subjects: 68
Study: 19639462

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (100 mg twice a day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ferrous sulfate (520 mg once a day)
Number of subjects: 100
Study: 17478172

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) leuprolide acetate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 15235144

Group type: EXPERIMENTAL
Intervention: Iron supplementation therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 32
Study: 12150492

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once-daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telithromycin
Number of subjects: 0
Study: 9640148

Group type: EXPERIMENTAL
Intervention: 8% sevoflurane and 60% nitrous oxide in oxygen
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5% halothane and 60% nitrous oxide in oxygen
Number of subjects: 40